In this engaging discussion, Nima Alidoust, CEO of Vevo Therapeutics, and Patrick Hsu, CEO of the Arc Institute, dive into the revolutionary Tahoe-100M dataset that is reshaping drug discovery. They explore the fascinating potential of virtual cell models and AI in understanding disease behaviors at a cellular level. The conversation highlights challenges in data collection and the critical need for high-quality datasets in biomedical research. They also discuss the importance of open-sourcing data to foster collaboration and innovation in the biotech field.
